Clinical Trial Update: Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial investigating gemcitabine hydrochloride and docetaxel followed by doxorubicin hydrochloride or observation in high-risk uterine leiomyosarcoma aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Leiomyosarcoma
• Uterine Sarcoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Stage I Uterine Sarcoma AJCC v7, Uterine Corpus Leiomyosarcoma | Phase 3 | Status: TERMINATED | Results posted: 2020-04-06